Literature DB >> 21208028

Diagnostic significance of Aspergillus species isolated from respiratory samples in an adult pneumology ward.

Takayoshi Tashiro1, Koichi Izumikawa, Masato Tashiro, Takahiro Takazono, Yoshitomo Morinaga, Kazuko Yamamoto, Yoshifumi Imamura, Taiga Miyazaki, Masafumi Seki, Hiroshi Kakeya, Yoshihiro Yamamoto, Katsunori Yanagihara, Akira Yasuoka, Shigeru Kohno.   

Abstract

Although the diagnostic significance of isolating Aspergillus spp. from respiratory cultures has been studied in immunocompromised hosts with invasive pulmonary aspergillosis (IPA), little is known of such infections in immunocompetent patients with other forms of aspergillosis. In this study of adult pneumology ward patients, we examined the association between Aspergillus spp. and disease prevalence. Laboratory records from April 1998 to March 2009 were reviewed to identify patients with Aspergillus spp. in respiratory samples. Correlations between the isolated species and clinical characteristics of patients were evaluated. During the study period, 165 Aspergillus spp. isolates were detected in the respiratory cultures of 139 patients. Of these patients, 62 (45%) were colonized with Aspergillus spp. and displayed no clinical symptoms of aspergillosis, while 77 (55%) had a form of pulmonary aspergillosis, characterized as either chronic necrotizing pulmonary aspergillosis (CNPA) (48%), aspergilloma (29%), IPA (13%), or allergic bronchopulmonary aspergillosis (ABPA) (10%). The dominant species were Aspergillus fumigatus (41%), A. niger (32%), and A. versicolor (12%). A. fumigatus was most commonly isolated in patients with IPA, aspergilloma, and CNPA, whereas A. niger was the dominant species in colonized patients and those with ABPA. Isolation of an Aspergillus spp. from respiratory samples does not confirm it as the etiologic pathogen because airway colonization by Aspergillus spp. is a common feature in several chronic lung diseases. Repeated isolation of the identical Aspergillus species and detection of anti-Aspergillus antibodies and/or Aspergillus antigens in sera are needed to determine the isolate represents the etiologic agent of disease.
© 2011 ISHAM

Entities:  

Mesh:

Year:  2011        PMID: 21208028     DOI: 10.3109/13693786.2010.548084

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  26 in total

1.  Evaluation of the Aspergillus Western blot IgG kit for diagnosis of chronic aspergillosis.

Authors:  A Oliva; P Flori; C Hennequin; J-C Dubus; M Reynaud-Gaubert; D Charpin; J M Vergnon; P Gay; A Colly; R Piarroux; H Pelloux; S Ranque
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

Review 2.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

3.  Clinical significance of Aspergillus species isolated from respiratory specimens in patients with Mycobacterium avium complex lung disease.

Authors:  K Furuuchi; A Ito; T Hashimoto; S Kumagai; T Ishida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-09-17       Impact factor: 3.267

Review 4.  How Environmental Fungi Cause a Range of Clinical Outcomes in Susceptible Hosts.

Authors:  Steven T Denham; Morgan A Wambaugh; Jessica C S Brown
Journal:  J Mol Biol       Date:  2019-05-09       Impact factor: 5.469

5.  Expression of sexual genes in Aspergillus fumigatus homogeneous culture produced by vegetative mass mating.

Authors:  Joo-Yeon Lim; Hee-Moon Park
Journal:  J Microbiol       Date:  2019-05-11       Impact factor: 3.422

6.  Drug Sensitivity and Resistance Mechanism in Aspergillus Section Nigri Strains from Japan.

Authors:  Aki Hashimoto; Daisuke Hagiwara; Akira Watanabe; Maki Yahiro; Alimu Yikelamu; Takashi Yaguchi; Katsuhiko Kamei
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

7.  Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.

Authors:  Masato Tashiro; Koichi Izumikawa; Asuka Minematsu; Katsuji Hirano; Naoki Iwanaga; Shotaro Ide; Tomo Mihara; Naoki Hosogaya; Takahiro Takazono; Yoshitomo Morinaga; Shigeki Nakamura; Shintaro Kurihara; Yoshifumi Imamura; Taiga Miyazaki; Tomoya Nishino; Misuzu Tsukamoto; Hiroshi Kakeya; Yoshihiro Yamamoto; Katsunori Yanagihara; Akira Yasuoka; Takayoshi Tashiro; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2011-10-24       Impact factor: 5.191

8.  Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus.

Authors:  Masato Tashiro; Koichi Izumikawa; Katsuji Hirano; Shotaro Ide; Tomo Mihara; Naoki Hosogaya; Takahiro Takazono; Yoshitomo Morinaga; Shigeki Nakamura; Shintaro Kurihara; Yoshifumi Imamura; Taiga Miyazaki; Tomoya Nishino; Misuzu Tsukamoto; Hiroshi Kakeya; Yoshihiro Yamamoto; Katsunori Yanagihara; Akira Yasuoka; Takayoshi Tashiro; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

Review 9.  Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways.

Authors:  Sanjay H Chotirmall; Maria Teresa Martin-Gomez
Journal:  Mycopathologia       Date:  2017-05-17       Impact factor: 2.574

10.  Pulmonary aspergillosis and aflatoxins in chronic lung diseases.

Authors:  Sana Ali; Abida Malik; Mohd Shahid; Rakesh Bhargava
Journal:  Mycopathologia       Date:  2013-08-15       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.